NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
Back to search
Official data from USPTO
HIPRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
12/09/2025
Trademark type
Combined
Nice classes
5, 42
Filing date
01/28/2022
Registration date
12/09/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
12/09/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-00-00
First use in commerce
07/23/2024
Drawing code
3
Owner type
99
Owner location
AMER (GIRONA), ES
Examiner
MAGIT, JACOB FLEMING
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "HIPRA" in white inside a blue rectangle.
Holders and representatives
Holders
LABORATORIOS HIPRA, S.A.
Representatives
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsbiological vaccines for human and veterinary use; biological preparations for medical and veterinary useveterinary vaccines; veterinary preparations for the treatment of intestinal bacteria; anti- infective products for veterinary use; insecticidal washing products for veterinary use; veterinary products and substancesvaccines for prevention of animal illness; biological reagents for veterinary use; diagnostic reagents for veterinary use; reagents for clinical analyses for veterinary purposes; reagents for microbiological analyses for veterinary purposes; reagents for chemical analyses for veterinary purposes; reagents for veterinary diagnosis; reagents for diagnostic tests for veterinary purposes; reagents for use with analyzers for veterinary purposes; reagents for use in analyses for veterinary usereagents for in-vitro laboratory use for veterinary purposes; reagents for use in analysis for veterinary usereagents for in-vitro laboratory use for veterinary purposes; chemical reagents for medical or veterinary purposes; chemical reagents for veterinary use; reagents and media for medical and veterinary diagnostic purposes; nucleic acid sequences for medical and veterinary use; dietary supplements for veterinary use; veterinary substances and preparationsvaccines for prevention of animal illness; oral vaccine preparations; vaccine preparations for human use; vaccines; influenza vaccines; vaccines against pneumococcal infections; vaccines for horses; vaccines for cattle; vaccines for infections in animal hooves; vaccines for human use; veterinary vaccines; viral vaccines
Class 42
Scientific and technological servicesas well as associated research and design servicesscientific researchanalysis and testing in the field of pharmaceuticalveterinarysanitary products and materialsurgicalmedicalveterinary apparatusdevicesinstruments; industrial analysis and research services in the field of pharmaceuticalveterinarysanitary products and materialsurgicalmedicalveterinary apparatusdevicesinstrumentsas well as of computer software related to the biomedical and pharmaceutical sectorindustrial design services; quality control services for others in the field of pharmaceuticalveterinarysanitary products and materialsurgicalmedicalveterinary apparatusdevices and instruments; design and development of computer hardware and software; research and development of vaccines; veterinary laboratory services; services for assessing the effectiveness of veterinary medicines; design of laboratory animal housing systems; biotechnology research for determining the neuronal survival of molecules in animal models; research regarding farm animal breeding; genetic tests of laboratory animals for research; consultancy in pharmaceutical research; consultancy related to pharmacology; consultancy related to pharmacogenetics research; consultancy related to pharmaceutical research and development; development of pharmaceutical preparations and medicines; development of pharmaceutical products; clinical studies for pharmaceutical products; evaluation of pharmaceutical products; scientific and medical research information regarding pharmaceutical products and clinical trials; inspection of pharmaceutical products; scientific research in the field of pharmaceuticals; research in the field of pharmacogenetics; research regarding pharmaceutical products; research and development in the field of pharmaceuticals and biotechnology; pharmaceutical research and development; research and development for the pharmaceutical industry; conducting clinical trials for pharmaceutical products; conducting early evaluations in relation to new pharmaceutical products; pharmaceutical drug development services; drug discovery services; pharmaceutical product efficacy assessment services; medical and pharmacological research services; pharmaceutical research and development services; information technology services for the pharmaceutical and health-care industriesinformation technology consulting services; provision of information regarding results of clinical trials relating to pharmaceutical products; electronic storage of medical records; design and development of medical diagnostic apparatus; scientific research for medical purposes; medical laboratories; programming for computers in the medical field; information and data services regarding medical and veterinary research and development; services of a medical laboratory; non-medical ultrasound imaging services; provision of scientific information regarding medical disorders and their treatment; research and development of vaccines and medicines; biological research and analysis; development of computer software in the pharmaceuticalmedicalveterinarysanitary and diagnostic field; clinical research in the field of veterinary preparationsbiotherapeutic medicinesantibodies; blood testing services for scientific research; scientific analysis services relating to the assessment of bacteria content in liquids
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/19/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/19/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/03/2025
IUAF
USE AMENDMENT FILED
06/18/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/18/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EX2G
SOU EXTENSION 2 GRANTED
12/19/2024
EXT2
SOU EXTENSION 2 FILED
12/19/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/19/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/20/2024
EX1G
SOU EXTENSION 1 GRANTED
06/20/2024
EXT1
SOU EXTENSION 1 FILED
06/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/20/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/24/2023
PUBO
PUBLISHED FOR OPPOSITION
10/24/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/06/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/12/2023
GNFR
FINAL REFUSAL E-MAILED
06/12/2023
CNFR
FINAL REFUSAL WRITTEN
06/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/23/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/23/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/23/2022
GNRT
NON-FINAL ACTION E-MAILED
11/23/2022
CNRT
NON-FINAL ACTION WRITTEN
11/23/2022
DOCK
ASSIGNED TO EXAMINER
11/09/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
02/24/2022
ALIE
ASSIGNED TO LIE
02/24/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2022
NWAP
NEW APPLICATION ENTERED
02/01/2022
Continuous trademark protection
Get notified about every new filing that threatens HIPRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.